References
- Breur JM, Udink Ten Cate FE et al. Pacemaker therapy in isolated congenital complete atrioventricular block. Pacing. Clin Electrophysiol. 2002; 25:1685-1691.
- Vanagt WY, Verbeek XA, Delhaas T et al. The left ventricular apex is the optimal site for pediatric pacing: correlation with animal experience. Pacing Clin Electrophysiol. 2004, 27:837-843.
- Healey JS, Toff WD, Lamas GA, et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation. 2006, 114:11-17.
- Boriani G, Tukkie R, Manolis AS et al. MINERVA Investigators. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Eur Heart J. 2014, 35:2352-2362.
- Burri H, Starck C, Auricchio A et al. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS). Europace. 2021, doi: 10.1093/europace/euaa367.
- Phyo AZZ, Freak-Poli R, Craig H et al. Quality of life and mortality in the general population: a systematic review and meta-analysis. BMC Public Health. 2020, 20(1):1596.
- Martinez R, Morsch P, Soliz P, et al. Life expectancy, healthy life expectancy, and burden of disease in older people in the Americas, 1990-2019: a population-based study. Rev Panam Salud Publica. 2021; 30(9):45-114.
- Li C, Li C, Bai W, et al. Value of three-dimensional speckle-tracking in detecting left ventricular dysfunction in patients with aortic valvular diseases. J Am Soc Echocardiogr. 2013; 26:1245-52.
- Xu H, Li J, Bao Z, et al. Early Change in Global Longitudinal Strain is an Independent Predictor of Left Ventricular Adverse Remodelling in Patients with Ventricular Apical Pacing. Heart, Lung and Circulation. 2019; 28(12):1780-1787. https://doi.org/10.1016/j.hlc.2018.11.004
- Cevher V, Karaaslan M, Akilli R, et al. Evaluation of the relationship between dyssynchrony and myocardial fibrosis markers in patients with cardiac resynchronization therapy. Ann Med Res. 2020; 27(4):1234-40. doi.org/10.1016/j.amjcard.2018.03.159
- Strauss D, Selvester R, Wagner G. Defining left bundle branch block in the era of cardiac resynchronization therapy. Am J Cardiol. 2011; 107:927-934. https://doi.org/10.1016/j.amjcard.2010.11.010
- Khurshid S, Epstein AE, Verdino RJ, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm. 2014; 11:1619-1625. http://dx.doi.org/10.1016/j.hrthm.2014.05.040
- Kiehl EL, Makki T, Kumar R, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm. 2016; 13:2272-2278.
- Bansal R, Parakh N, Gupta A et al. Incidence and predictors of pacemaker-induced cardiomyopathy with comparison between apical and non-apical right ventricular pacing sites. J Interv Card Electrophysiol. 2019, 56:63-70. doi.org/10.1007/s10840-019-00602-2
- Hussain M, Furuya-Kanamori L, Kaye G, et al. The Effect of Right Ventricular Apical and Nonapical Pacing on the Short- and Long-Term Changes in Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials. Pacing and Clinical Electrophysiology. 2015; 38(9):1121-1136. doi:10.1111/pace.1268110.1111/pace.12681
- Cano O, Andres A, Alonso P, et al. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads. Europace. 2017; 19:96-102.
- Zanon F, Ellenbogen K, Dandamudi G et al. Permanent Hisbundle pacing: a systematic literature review and meta-analysis. Europace. 2018; 20:1819-1826. https://doi.org/10.1093/europace/euy058.
- Leong DP, Mitchell AM, Salna I et al. Long-term mechanical consequences of permanent right ventricular pacing: Effect of pacing site. J Cardiovasc Electrophysiol. 2010; 21:1120-1126.
- Lewicka-Nowak E, Dabrowska-Kugacka A, Tybura S et al. Right ventricular apex versus right ventricular outflow tract pacing: Prospective, randomised, long-term clinical and echocardiographic evaluation. Kardiol Pol. 2006; 64:1082-1091.
- Flevari P, Theodorakis G, Leftheriotis D. Serum markers of deranged myocardial collagen turnover: Their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure. Am. Heart J. 2012; 164:530-537. https://doi.org/10.1016/j.ahj.2012.07.006
- Cano O, Osca J, Sancho-Tello MJ et al. Comparison of effectiveness of right ventricular septal pacing versus right ventricular apical pacing. Am J Cardiol. 2010; 105:1426–1432.
- Ferrario C. Cardiac remodelling and RAS inhibition. Therapeutic Advances in Cardiovascular Disease. 2016; 10(3):162-171. doi: 10.1177/1753944716642677
- Ahmed M, Gorcsan 3rd J, Marek J, et al. Right ventricular apical pacing-induced left ventricular dyssynchrony is associated with a subsequent decline in ejection fraction. Heart Rhythm. 2014; 11:602-8.
- Kai H, Mori T, Tokuda K, et al. Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II. Hypertens Res. 2006; 29:711-718.
- Jong S, Veen T, Rijen H, et al. Fibrosis and cardiac arrhythmias. J Cardiovasc Pharmacol, 2011; 57:630-638. doi: 10.1097/FJC.0b013e318207a35f
- Creemers EE, Pinto YM. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res. 2011; 89:265-272. doi:10.1093/cvr/cvq308
- Suthahar N, Meijers WC, Silljé HHW, et al. From inflammation to fibrosis-molecular and cellular mechanisms of myocardial tissue remodelling and perspectives on differential treatment opportunities. Curr Heart Fail Rep. 2017; 14:235-250.
- Besler C, Lang D, Urban D et al. Plasma and cardiac galectin-3 in patients with heart failure reflects both inflammation and fibrosis: implications for its use as a biomarker. Circ Heart Fail. 2017;10(3). DOI:10.1161/CIRCHEARTFAILURE.116.003804
- Schirone L, Forte M, Palmerio S, et al. A review of the molecular mechanisms underlying the development and progression of cardiac remodeling. Oxid Med Cell Longev. 2017; (3920195):1-16.
- Ziegler KA, Ahles A, Wille T, et al. Local sympathetic denervation attenuates myocardial inflammation and improves cardiac function after myocardial infarction in mice. Cardiovasc Res. 2018; 114:291-299.
- Kang M, Ragan BG, Park JH. Issues in outcomes research: an overview of randomization techniques for clinical trials. J Athl Train. 2008; 43(2):215-221
- Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015; 16(3):233-270
- Lee M, Dae M, Langberg J, et al. Effects of long-term right ventricular apica pacing on left ventricular perfusion, innervation, function and histology. Journal of the American College of Cardiology. 1994; 24(1):225-232. https://doi.org/10.1016/0735-1097(94)90567-3
- Ravassa S, Ballesteros G, Lopez B, et al. Combination of circulating type I collagen-related biomarkers is associated with atrial fibrillation. J. Am. Coll. Cardiol. 2019; 73: 1398-141.
- Ducharme A, Frantz S, Aikawa M, et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest. 2000; 106:55-62.
- Spinale FG: Matrix metalloproteinases: Regulation and dysregulation in the failing heart. Circ Res. 2002; 90:520-530.
- Lin L, Lai L, Lin C et al. Left Ventricular Extracellular Matrix Remodeling in Dogs with Right Ventricular Apical Pacing. J Cardiovasc Electrophysiol, 2010; 21(10):1142-1149. doi:10.1111/j.1540-8167.2010.01765.x
- Kong P, Christia P, Frangogiannis N. The pathogenesis of cardiac fibrosis. Cell Mol. Life Sci. 2014; 71:549-574. https://doi.org/10.1007/s00018-013-1349-6
- Jarvelainen H, Sainio A, Koulu M, et al. Extracellular matrix molecules: Potential targets in pharmacotherapy. Pharmacol. Rev. 2009; 61:198-223. doi.org/10.1124/pr.109.001289
- Espeland T, Lunde I, Amundsen B, et al. Myocardial fibrosis. Tidsskriftet. 2018; 138. doi: 10.4045/tidsskr.17.1027
- Segura A, Frazier O, and Buja L. Fibrosis and heart failure. Heart Fail. Rev. 2014; 19:173-185. doi: 10.1007/s10741-012-9365-4
- Prockop D and Kivirikko K. Collagens: molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem. 1995; 64:403-434. doi: 10.1146/annurev.bi.64.070195.002155
- Lopez B, Gonzalez A, Ravassa S et al. Circulating biomarkers of myocardial fibrosis: the need for a reappraisal. J. Am. Coll. Cardiol. 2015; 65:2449-2456. doi: 10.1016/j.jacc.2015.04.026
- Uchinaka A, Yoshida M, Tanaka K, et al. Overexpression of collagen type III in injured myocardium prevents cardiac systolic dysfunction by changing the balance of collagen distribution. The Journal of Thoracic and Cardiovascular Surgery. 2018; 156(1):217-226. https://doi.org/10.1016/j.jtcvs.2018.01.097
- Riekki R, Harvima, JI, Ristile J, Oikarinen A. The production of collagen and the activity of mast-cell chymase increase in human skin after irradiation therapy. Experimental Dermatology. 2004; 13(6):364-371. https://doi.org/10.1111/j.0906-6705.2004.00164.x
- Haukipuro K, Risteli L, Kairaluoma M, et al. Aminoterminal propeptide of type III procollagen in healing wound in humans. Ann Surg 1987; 206:752-756. doi: 10.1097/00000658-198712000-00011
- Zile M, Desantis S, Baicu C et al. Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure. Circ Heart Fail 2011; 4:246-256. https://doi.org/10.1161/CIRCHEARTFAILURE.110.958199
- Michalski B, Trzcinski P, Kupczynska K et al, The differences in the relationship between diastolic dysfunction, selected biomarkers and collagen turn-over in heart failure patients with preserved and reduced ejection fraction. Cardiol J. 2017; 24:35-42. DOI: 10.5603/CJ.a2016.0098
- Duprez D, Gross M, Kizer J, et al. Predictive value of collagen biomarkers for heart failure with and without preserved ejection fraction: MESA (Multi – Ethnic Study of Atherosclerosis). J Am Heart Assoc. 2018; 7:e007885. https://doi.org/10.1161/JAHA.117.007885
- Löfsjögård J, Thomas K, Javier D et al. Biomarkers of collagen type I metabolism are related to B-type natriuretic peptide, left ventricular size, and diastolic function in heart failure. J Cardiovasc Med, 2014; 15(6):463-469; doi: 10.2459/01. JCM.0000435617.86180.0
- Flevari P, Leftheriotis D, Fountoulaki K, et al. Long-term nonoutflow septal versus apical right ventricular pacing: Relation to left ventricular dyssynchrony. Pacing Clin Electrophysiol. 2009; 32:354-362.
- Velagaleti R, Vasan R. Heart failure in the twenty-first century: is it a coronary artery disease or hypertension problem? Cardiol Clin. 2007; 25:487-495. doi.org/10.1016/j.ccl.2007.08.010
- McMurray J, Adamopoulos S, Anker S et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012; 33:1787-1847. DOI: 10.1093/eurheartj/ehs104